Cargando…
How the concept of WHO-listed authorities will change international procurement policies for medicines
Autores principales: | Macé, Cécile, Rägo, Lembit, Ravinetto, Raffaella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883025/ https://www.ncbi.nlm.nih.gov/pubmed/35144982 http://dx.doi.org/10.1136/bmjgh-2021-008109 |
Ejemplares similares
-
Quality of medicines in resource-limited settings: need for ethical guidance
por: Ravinetto, Raffaella, et al.
Publicado: (2018) -
Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries
por: Perrin, Christophe, et al.
Publicado: (2020) -
The Belgian commitment to pharmaceutical quality: a model policy to improve quality assurance of medicines available through humanitarian and development programs
por: Ravinetto, Raffaella, et al.
Publicado: (2018) -
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
por: Ravinetto, Raffaella, et al.
Publicado: (2016) -
Drug procurement, the Global Fund and misguided competition policies
por: Tren, Richard, et al.
Publicado: (2009)